Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: June 14, 2012
Last updated: September 13, 2012
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)